Aehr Test Systems (AEHR) reported record third-quarter 2026 bookings of $37.2 million and a book-to-book ratio of over 3.5x, driven by increased backlog from orders for AI processors and silicon photonics.
See our latest analysis for Aehr Test Systems.
The surge in bookings and backlog has coincided with the stock’s strong momentum, with the stock’s 30-day stock return of 97.45% and year-to-date stock return of 217.82%. The total shareholder return for the year is very strong, demonstrating enthusiasm for Aehr’s role in AI-focused testing.
If you’re interested in this kind of AI-driven story, it might be worth checking out 36 AI Infrastructure Stocks to see how other chip and AI names are doing.
AEHR is currently trading at $70.43, above the analyst price target of $54, and has recently reported record bookings with losses, but is this a bubble story for AI or is the market simply pricing in future growth?
49x asking price to sales: Is it justified?
Aehr Test Systems currently trades at a P/S ratio of 49x, which stands out compared to its peers and the U.S. semiconductor industry as a whole.
The P/S multiple compares a company’s market value to its earnings. This is useful if your business is not profitable and revenue-based metrics are not very informative. In Aehr’s case, this lens is important because even with its stock price soaring, the company reported a net loss of $11.42 million on revenue of $45.26 million.
According to data from Simply Wall St, Aehr has a P/S multiple of 49x, compared to 12x for its peers. This is also significantly higher than the U.S. semiconductor industry average of 5.9x, and higher than the 10.1x fair P/S ratio that regression analysis suggests could move the market in this direction if sentiment cools.
Explore Aehr Test Systems’ SWS Fairness Ratio
Result: Preferred price-to-sales multiple of 49x (overvalued)
However, the current P/S is 49 times, the net loss continues to be USD 11.42 million, and the stock price exceeds the analyst target of USD 54, so there is limited room for execution errors.
Learn about the key risks to this Aehr Test Systems story.
next step
Given the mix of excitement and clear risks and rewards in this story, it makes sense to take a quick look at the big picture and shape your view with the help of 1 significant reward and 2 significant warning signs.
Looking for more investment ideas?
If you’re interested in Aehr, don’t stop here. Use this momentum to expand your watchlist to include other focused ideas that fit your style.
This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
new: Manage all your stock portfolios in one place
What we created is The ultimate portfolio companion For stock investors, And it’s free.
• Connect an unlimited number of portfolios and see the total in one currency
• Alert you to new warning signs and risks via email or mobile phone
• Track the fair value of stocks
Try our demo portfolio for free
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.
